Alcon Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 25-11-2024
- Paid Up Capital ₹ 1.03 Cr
as on 25-11-2024
- Company Age 42 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 24.22 Cr
as on 25-11-2024
- Satisfied Charges ₹ 37.16 Cr
as on 25-11-2024
About Alcon Biosciences
The Corporate was formerly known as Alcon Pharamaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.03 Cr.
The company currently has active open charges totaling ₹24.22 Cr. The company has closed loans amounting to ₹37.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishal Jajodia, Advait Jajodia, and Kalpesh Sharma serve as directors at the Company.
- CIN/LLPIN
U24230MH1982PTC026953
- Company No.
026953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alcon Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Jajodia  | Director | 07-Dec-2003 | Current |
| Advait Jajodia | Director | 24-Jun-2023 | Current |
| Kalpesh Sharma | Director | 24-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Alcon Biosciences.
Alcon Biosciences Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Alcon Biosciences?
In 2024, Alcon Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Banwarri Prahladrai Poddar Technologies Private LimitedActive 37 years 26 daysVishal Jajodia is a mutual person
- Renewable Energy Carbon Credits Private LimitedActive 13 years 8 months
Vishal Jajodia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Aug 2022 | ₹2.70 Cr | Open |
Others Creation Date: 11 Jan 2022 | ₹2.41 Cr | Open |
Others Creation Date: 27 Jun 1998 | ₹19.11 Cr | Open |
How Many Employees Work at Alcon Biosciences?
Alcon Biosciences has a workforce of 108 employees as of Nov 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alcon Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alcon Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
